Characteristics of Epidermal Growth Factor Receptor with Rare Mutations in Non-small Cell Lung Cancer and the Effect of EGFR Tyrosine Kinase Inhibitors on Them

Background and objective Adenocarcinoma is the most common type of lung cancer. It has been clinically evaluated that therapiestargeting against the epidermal growth factor receptor (EGFR) as the clinical standard first-line treatment. The response and outcome of EGFR-tyrosine kinase inhibitors (TKI...

Ausführliche Beschreibung

Bibliografische Detailangaben

Hauptverfasser:	Yunshu SHI, Panhua LI, Banban LI, Fengming ZHANG, Siyuan HUANG, Shujing SHEN, Xingya LI
Format:	Artigo
Sprache:	Chinês
Veröffentlicht:	Chinese Anti-Cancer Association; Chinese Antituberculosis Association 2019-05-01
Schriftenreihe:	Chinese Journal of Lung Cancer
Schlagworte:	Lung neoplasms EGFR Mutation Target therapy EGFR-TKIs
Online-Zugang:	http://dx.doi.org/10.3779/j.issn.1009-3419.2019.05.06
Tags:	Tag hinzufügen Keine Tags, Fügen Sie das erste Tag hinzu!